The proceeds from the seed round will enable the company to fund the development and commercial launch of a $15 genomic test for dairy and beef cattle.
Investors in Theranos may lose out and some are filing lawsuits, the Wall Street Journal reports.
UgenTec will use the funds to develop new features for its FastFinder software that will be released next year, as well to expand its sales efforts.
ImmunArray will use Quanterix's Simoa single-molecule array technology for biomarker analysis, with the potential to enrich its diagnostic panels.
The genomic data startup company said it will use the funds to market and sell its clinical software products around the world.
The DNA foundries have been funded through an £18 million ($23.5 million) investment from the BBSRC and should all be fully operational by next year.
The startup, which was founded in 2015 by former BGI employees, is developing next-generation sequencing tests for cancer applications.
William Bains at the Trade Secrets blog examines the behavior of biotech investors in different parts of the world.
N-of-One will use the funds to develop new oncology clinical decision support solutions, and to expand its sales and marketing efforts.
The company said the funding round raised nearly $140 million overall.
A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.
Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.
In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.
A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.